Improvement after cerebrospinal fluid drainage is related to levels of N-acetyl-aspartate in idiopathic normal pressure hydrocephalus

Neurosurgery

Volumn 62, Issue 1, 2008, Pages 135-141

  Lenfeldt, Niklas ^a   Hauksson, Jon ^a   Birgander, Richard ^a   Eklund, Anders ^a   Malm, Jan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Ischemia; Lactate; Lumbar puncture; N acetyl aspartate; Neuronal integrity; Periventricular white matter lesions; Spectroscopy

Indexed keywords

CHOLINE; CREATINE; LACTIC ACID; N ACETYLASPARTIC ACID; ASPARTIC ACID; DIAGNOSTIC AGENT; DRUG DERIVATIVE; N-ACETYLASPARTATE; PROTON; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID DRAINAGE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GAIT; HUMAN; INTRACRANIAL PRESSURE; MALE; MOTOR PERFORMANCE; NORMOTENSIVE HYDROCEPHALUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; VIDEORECORDING; WHITE MATTER; CEREBROSPINAL FLUID SHUNTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

AGED; ASPARTIC ACID; CEREBROSPINAL FLUID SHUNTS; FEMALE; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS;

EID: 41749124604     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000311070.25992.05     Document Type: Article

References (59)

1. Adalsteinsson E, Sullivan EV, Kleinhans N, Spielman DM, Pfefferbaum A: Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet 355:1696-1697, 2000.
2. Ågren-Wilsson A: Cerebrospinal fluid biochemical markers in the evaluation of idiopathic adult hydrocephalus syndrome, in: On the pathophysiology of idiopathic adult hydrocephalus syndrome. Umeå, Sweden, Umeå University, Department of Pharmacology and Clinical Neuroscience and Department of Radiation Sciences, 2005, pp 66-79 (thesis).
3. Agren-Wilsson A, Eklund A, Koskinen LO, Bergenheim AT, Malm J: Brain energy metabolism and intracranial pressure in idiopathic adult hydrocephalus syndrome. J Neurol Neurosurg Psychiatry 76:1088-1093, 2005.
4. Agren-Wilsson A, Roslin M, Eklund A, Koskinen LO, Bergenheim AT, Malm J: Intracerebral microdialysis and CSF hydrodynamics in idiopathic adult hydrocephalus syndrome. J Neurol Neurosurg Psychiatry 74:217-221, 2003.
5. Arnold DL, Shoubridge EA, Villemure JG: Phosphorus MRS reveals reversible periventricular acidosis in patients with normal pressure hydrocephalus, in Proc 7th SMRM 332, 1988 (abstr).
6. Baloh RW: White matter abnormalities and gait disorders in older people. J Neurol Sci 232:1-2, 2005.
7. Bateman GA: Ventricular lactate in normal pressure hydrocephalus: From where has it come to where does it go? AJNR Am J Neuroradiol 23:1061-1062, 2002.
8. Bergsneider M, Black PM, Klinge P, Marmarou A, Relkin N: Surgical management of idiopathic normal-pressure hydrocephalus. Neurosurgery 57 [Suppl 3]:S29-S39, 2005.
9. Bottomley PA: Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 508:333-348, 1987.
10. Bradley WG: Normal pressure hydrocephalus and deep white matter ischemia: Which is the chicken, and which is the egg? AJNR Am J Neuroradiol 22:1638-1640, 2001.
11. Braun KP, Gooskens RH, Vandertop WP, Tulleken CA, van der Grond J: 1H magnetic resonance spectroscopy in human hydrocephalus. J Magn Reson Imaging 17:291-299, 2003.
12. Braun KP, Vandertop WP, Gooskens RH, Tulleken KA, Nicolay K: NMR spectroscopic evaluation of cerebral metabolism in hydrocephalus: A review. Neurol Res 22:51-64, 2000.
13. Confort-Gouny S, Vion-Dury J, Nicoli F, Dano P, Donnet A, Grazziani N, Gastaut JL, Grisoli F, Cozzone PJ: A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases. J Neurol Sci 118:123-133, 1993.
14. Corkill RG, Garnett MR, Blamire AM, Rajagopalan B, Cadoux-Hudson TA, Styles P: Multi-modal MRI in normal pressure hydrocephalus identifies preoperative haemodynamic and diffusion coefficient changes in normal appearing white matter correlating with surgical outcome. Clin Neurol Neurosurg 105:193-202, 2003.
15. Corrigan JD, Hinkeldey NS: Relationships between parts Aand B of the Trail Making Test. J Clin Psychol 43:402-409, 1987.
16. Danielsen ER, Ross B: Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York, Marcel Dekker, 1999, pp 5-52.
17. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 149:351-356, 1987.
18. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198, 1975.
19. Haan J, Thomeer RT: Predictive value of temporary external lumbar drainage in normal pressure hydrocephalus. Neurosurgery 22:388-391, 1988.
20. Haase A, Frahm J, Hanicke W, Matthaei D: 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 30:341-344, 1985.
21. Hanstock CC, Rothman DL, Prichard JW, Jue T, Shulman RG: Spatially localized 1H NMR spectra of metabolites in the human brain. Proc Natl Acad Sci U S A 85:1821-1825, 1988.
22. Henry Feugeas MC, De Marco G, Peretti II, Godon-Hardy S, Fredy D, Claeys ES: Age-related cerebral white matter changes and pulse-wave encephalopathy: Observations with three-dimensional MRI. Magn Reson Imaging 23:929-937, 2005.
23. Hugg JW, Matson GB, Twieg DB, Maudsley AA, Sappey-Marinier D, Weiner MW: Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains. Magn Reson Imaging 10:227-243, 1992.
24. Jessen F, Block W, Träber F, Keller E, Flacke S, Papassotiropoulos A, Lamerichs R, Heun R, Schild HH: Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 55:684-688, 2000.
25. Jung RE, Brooks WM, Yeo RA, Chiulli SJ, Weers DC, Sibbitt WL Jr: Biochemical markers of intelligence: Aproton MR spectroscopy study of normal human brain. Proc Biol Sci 266:1375-1379, 1999.
26. Jung RE, Yeo RA, Chiulli SJ, Sibbitt WL Jr, Weers DC, Hart BL, Brooks WM: Biochemical markers of cognition: Aproton MR spectroscopy study of normal human brain. Neuroreport 10:3327-3331, 1999.
27. Kapeller P, Ropele S, Enzinger C, Lahousen T, Strasser-Fuchs S, Schmidt R, Fazekas F: Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy. J Neurol 252:1229-1234, 2005.
28. Kellor M, Frost J, Silberberg N, Iversen I, Cummings R: Hand strength and dexterity. Am J Occup Ther 25:77-83, 1971.
29. Kilic K, Czorny A, Auque J, Berkman Z: Predicting the outcome of shunt surgery in normal pressure hydrocephalus. J Clin Neurosci 14:729-736, 2007.
30. Kizu O, Yamada K, Nishimura T: Proton chemical shift imaging in normal pressure hydrocephalus. AJNR Am J Neuroradiol 22:1659-1664, 2001.
31. Klinge P, Marmarou A, Bergsneider M, Relkin N, Black PM: Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patients. Neurosurgery 57 [Suppl]:S40-S52, 2005.
32. Kristensen B, Malm J, Fagerlund M, Hietala SO, Johansson B, Ekstedt J, Karlsson T: Regional cerebral blood flow, white matter abnormalities, and cerebrospinal fluid hydrodynamics in patients with idiopathic adult hydrocephalus syndrome. J Neurol Neurosurg Psychiatry 60:282-288, 1996.
33. Luyten PR, den Hollander JA: Observation of metabolites in the human brain by MR spectroscopy. Radiology 161:795-798, 1986.
34. Malm J, Eklund A: Idiopathic normal pressure hydrocephalus. Pract Neurol 6:14-27, 2006.
35. Malm J, Kristensen B, Stegmayr B, Fagerlund M, Koskinen LO: Three-year survival and functional outcome of patients with idiopathic adult hydrocephalus syndrome. Neurology 55:576-578, 2000.
36. Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM: The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery 57 [Suppl 2]:S17-S28, 2005.
37. Marmarou A, Young HF, Aygok GA, Sawauchi S, Tsuji O, Yamamoto T, Dunbar J: Diagnosis and management of idiopathic normal-pressure hydrocephalus: Aprospective study in 151 patients. J Neurosurg 102:987-997, 2005.
38. Momjian S, Owler BK, Czosnyka Z, Czosnyka M, Pena A, Pickard JD: Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus. Brain 127:965-972, 2004.
39. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D: Java-based graphical user interface for the MRUI quantitation package. MAGMA 12:141-152, 2001.
40. Oppenheimer SM, Bryan RN, Conturo TE, Soher BJ, Preziosi TJ, Barker PB: Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. Magn Reson Med 33:61-68, 1995.
41. Owler BK, Pena A, Momjian S, Czosnyka Z, Czosnyka M, Harris NG, Smielewski P, Fryer T, Donvan T, Carpenter A, Pickard JD: Changes in cerebral blood flow during cerebrospinal fluid pressure manipulation in patients with normal pressure hydrocephalus: Amethodological study. J Cereb Blood Flow Metab 24:579-587, 2004.
42. Owler BK, Pickard JD: Normal pressure hydrocephalus and cerebral blood flow: A review. Acta Neurol Scand 104:325-342, 2001.
43. Persson L, Valtysson J, Enblad P, Warme PE, Cesarini K, Lewen A, Hillered L: Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg 84:606-616, 1996.
44. Reitan RM: Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271-276, 1958.
45. Sappey-Marinier D, Deicken RF, Fein G, Calabrese G, Hubesch B, Van Dyke C, Dillon WP, Davenport L, Meyerhoff DJ, Weiner MW: Alterations in brain phosphorus metabolite concentrations associated with areas of high signal intensity in white matter at MR imaging. Radiology 183:247-256, 1992.
46. Shiino A, Nishida Y, Yasuda H, Suzuki M, Matsuda M, Inubushi T: Magnetic resonance spectroscopic determination of a neuronal and axonal marker in white matter predicts reversibility of deficits in secondary normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 75:1141-1148, 2004.
47. Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD: Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 195:65-72, 1995.
48. Simmons ML, Frondoza CG, Coyle JT: Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45:37-45, 1991.
49. Strauss I, Williamson JM, Bertram EH, Lothman EW, Fernandez EJ: Histological and 1H magnetic resonance spectroscopic imaging analysis of quinolinic acid-induced damage to the rat striatum. Magn Reson Med 37:24-33, 1997.
50. Synek V, Reuben JR, Du Boulay GH: Comparing Evans' index and computerized axial tomography in assessing relationship of ventricular size to brain size. Neurology 26:231-233, 1976.
51. Tinetti ME: Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 34:119-126, 1986.
52. Tullberg M, Hultin L, Ekholm S, Månsson JE, Fredman P, Wikkelsø C: White matter changes in normal pressure hydrocephalus and Binswanger disease: Specificity, predictive value and correlations to axonal degeneration and demyelination. Acta Neurol Scand 105:417-426, 2002.
53. Tullberg M, Rosengren L, Blomsterwall E, Karlsson JE, Wikkelsö C: CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology 50:1122-1127, 1998.
54. Urenjak J, Williams SR, Gadian DG, Noble M: Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13:981-989, 1993.
55. Walchenbach R, Geiger E, Thomeer RT, Vanneste JA: The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 72:503-506, 2002.
56. van der Boogaart A, van Ormondt D, Pijnappel WWF, de Beer R, Ala-Korpela M, in McWhirter JG (ed): In Mathematics in Signal Processing III. Oxford, Clarendon Press, 1994, pp 175-195.
57. van der Knaap MS, van der Grond J, Luyten PR, den Hollander JA, Nauta JJ, Valk J: 1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. Ann Neurol 31:202-211, 1992.
58. Vanhamme L, van den Boogaart A, Van Huffel S: Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35-43, 1997.
59. Williams MA, Razumovsky AY, Hanley DF: Comparison of Pcsf monitoring and controlled CSF drainage diagnose normal pressure hydrocephalus. Acta Neurochir Suppl 71:328-330, 1998.